Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dinesh Pubbi

Clinical Cardiac Electrophysiology Jacksonville, FL Medical Doctor

NPI 1861454423 CMS profile 1099705

3901 University Blvd S Ste 221, Jacksonville, FL 32216

Open in the dashboard

General payments

$25,521

732 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$29,500 paid to institutions, not to them · program year 2021

Through program year 2025, Dinesh Pubbi of Jacksonville, FL is reported in the CMS Open Payments database as having received $25,521 across 732 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $29,500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 57th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,599 75
2024 General $2,698 106
2023 General $3,960 132
2022 General $2,395 117
2021 General $3,910 112
2020 General $4,335 99
2019 General $5,625 91

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dinesh Pubbi
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Dinesh Pubbi were reported at $2,599. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Dinesh Pubbi Clinical Cardiac Electrophysiology median Middle half National median
2019 $5,625 $2,361 $585–$8,260 $163
2020 $4,335 $993 $247–$4,351 $114
2021 $3,910 $1,185 $326–$4,739 $132
2022 $2,395 $2,073 $554–$6,789 $149
2023 $3,960 $2,568 $759–$8,159 $160
2024 $2,698 $2,557 $703–$7,403 $164
2025 $2,599 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sanofi-Aventis U.S. LLC $6,815 45 payments
  2. Medtronic, Inc. $4,895 128 payments
  3. Medtronic Vascular, Inc. $2,883 42 payments
  4. Boston Scientific Corporation $2,322 92 payments
  5. Abbott Laboratories $1,317 45 payments
  6. E.R. Squibb & Sons, L.L.C. $974 89 payments
  7. Janssen Pharmaceuticals, Inc $960 76 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $954 21 payments
  9. Novartis Pharmaceuticals Corporation $773 49 payments
  10. Merck Sharp & Dohme Corporation $488 27 payments
  11. Other $3,142 118 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $16,417 714 payments
  2. Consulting Fee $6,304 3 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,800 1 payment
  4. Travel and Lodging $829 5 payments
  5. Education $171 9 payments
Products named General payments · program years 2019–2025
  1. DISEASE STATE $3,969 2 payments
  2. MULTAQ $2,183 14 payments
  3. Micra $1,889 65 payments
  4. DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER $1,178 12 payments
  5. XARELTO $960 76 payments
  6. ELIQUIS $681 67 payments
  7. VERQUVO $593 32 payments
  8. COBALT DR MRI SURESCAN $552 15 payments
  9. PRADAXA $545 1 payment
  10. LINQ II $530 11 payments
  11. Other $10,578 448 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 46 drugs

Part D claims

4,412

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$1,654,429

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

49.5%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 904 $969,747
Xarelto Rivaroxaban Brand 282 $304,577
Multaq Dronedarone Hcl Brand 126 $160,344
Entresto Sacubitril/Valsartan Brand 108 $121,669
Dofetilide Generic 109 $21,488
Farxiga Dapagliflozin Propanediol Brand 11 $17,370
Jardiance Empagliflozin Brand 17 $12,835
Dabigatran Etexilate Dabigatran Etexilate Mesylate Brand 24 $6,326
Sotalol Sotalol Hcl Brand 357 $6,276
Metoprolol Succinate Generic 277 $4,864

The 10 drugs with the highest cost, of 46 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 57 billing codes

Paid by Medicare

$364,362

Medicare's payments for the services billed

Medicare patients

1,445

Average age 77

Services billed

3,841

678 women, 767 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 63%
Arthritis 56%
Ischemic heart disease 53%
Heart failure 34%
Diabetes 33%
Chronic kidney disease 33%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $160
$160 282 —
MULTAQ
  • SANOFI-AVENTIS U.S. LLC $141
$141 126 —
VERQUVO
  • Merck Sharp & Dohme Corporation $105
$105 — —
LEQVIO
  • Novartis Pharmaceuticals Corporation $84
$84 — —
CAMZYOS
  • E.R. Squibb & Sons, L.L.C. $83
$83 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

732 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record